Related Experiment Video
Updated: May 11, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization
Hugo Lavoie1, Neroshan Thevakumaran, Gwenaëlle Gavory
1Institute for Research in Immunology and Cancer, Laboratory of Intracellular Signalling, Université de Montréal, Montréal, Québec, Canada.
Nature Chemical Biology
|May 21, 2013
Summary
New biosensors detect RAF kinase dimerization, revealing how some inhibitors unexpectedly promote cancer cell growth by stabilizing kinase domains. This finding aids in developing targeted cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- RAF kinases are crucial in cancer development and are activated through kinase domain dimerization.
- Certain ATP-competitive RAF inhibitors paradoxically promote RAF dimerization and RAS/ERK pathway activation, leading to unwanted cell proliferation.
- The precise mechanism behind inhibitor-induced RAF dimerization remains poorly understood.
Purpose of the Study:
- To develop novel bioluminescence resonance energy transfer (BRET)-based biosensors for detecting RAF kinase dimerization in living cells.
- To utilize these biosensors for profiling RAF kinase inhibitors and understanding their effects on dimerization.
- To investigate the structural basis of RAF dimerization in vivo and its modulation by inhibitors.
Main Methods:
- Development and application of BRET-based biosensors tailored for the extended RAF kinase family.
- Live-cell imaging techniques to monitor RAF dimerization dynamics.
- Inhibitor profiling assays to assess their impact on RAF dimerization and kinase activity.
Main Results:
- Successfully established BRET biosensors capable of detecting RAF dimerization in real-time within living cells.
- Demonstrated the utility of these biosensors in identifying inhibitors that selectively modulate RAF dimerization.
- Provided insights into the structural mechanisms by which ATP-competitive inhibitors induce RAF dimerization, suggesting stabilization of a closed kinase domain conformation.
- Observed that this dimerization mechanism may be generalizable to other allosterically regulated kinase families.
Conclusions:
- BRET biosensors offer a powerful tool for studying RAF kinase dimerization and for the rational design of targeted cancer therapies.
- Understanding inhibitor-induced dimerization is critical for avoiding paradoxical activation of cancer-promoting pathways.
- The findings propose a generalizable model for allosteric regulation of kinase dimerization by ATP-competitive inhibitors.
More Related Videos
Related Concept Videos
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...